|
Disease |
|
|
|
Detail |
| hsa-let-7a-1 |
|
Causal |
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. |
2006 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. |
2007 |
|
|
|
|
|
|
| hsa-let-7g |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-15b |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-let-7b |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-107 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-10a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-181b |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-132 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-23a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-26a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-27a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-27b |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-296 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-30a-3p |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-30a-5p |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-30c |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-320 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-339 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-372 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-181a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-125a |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-191 |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-let-7f-1 |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-7-3 |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-10a |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-107 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-128b |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-155 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-223 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-24-1 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-24-2 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-29b-2 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-30c |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-32 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-191 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-181b |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-124a |
|
Causal |
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-133b |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-135b |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-96 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-129 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-19a |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-30a-3p |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-31 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-328 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-124a |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-127 |
|
Causal |
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. |
2006 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
MicroRNA-143 and -145 in colon cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNA-143 and -145 in colon cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-31 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Reduced accumulation of specific microRNAs in colorectal neoplasia. |
2003 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Reduced accumulation of specific microRNAs in colorectal neoplasia. |
2003 |
|
|
|
|
|
|
| hsa-miR-15b |
|
Unspecified |
Prognostic Values of microRNAs in Colorectal Cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-181b |
|
Unspecified |
Prognostic Values of microRNAs in Colorectal Cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Prognostic Values of microRNAs in Colorectal Cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-191 |
|
Unspecified |
Prognostic Values of microRNAs in Colorectal Cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-17-92 |
|
Causal |
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. |
2006 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. |
2006 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. |
2006 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells |
2009 |
|
|
|
|
|
|
| hsa-miR-141 |
|
Causal |
MicroRNA-141 Regulates Smad Interacting Protein 1 (SIP1) and Inhibits Migration and Invasion of Colorectal Cancer Cells |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells |
2009 |
|
|
|
|
|
|
| hsa-miR-1 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-10b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-125a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-133a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-139 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-195 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-30a-3p |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-30a-5p |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-30c |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-378* |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-422a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-422b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-497 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-95 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-106b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-130b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-181b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-19a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-19b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-224 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-29a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-96 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-182 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-18a |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-31 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
Deregulated expression of miR-106a predicts survival in human colon cancer patients. |
2008 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
Deregulated expression of miR-106a predicts survival in human colon cancer patients. |
2008 |
|
|
|
|
|
|
| hsa-miR-342 |
|
Causal |
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-34b |
|
Causal |
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-34c |
|
Causal |
Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-126 |
|
Causal |
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.
|
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-320 |
|
Unspecified |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-92 |
|
Unspecified |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
Role of miR-143 targeting KRAS in colorectal tumorigenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-192 |
|
Causal |
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. |
2009 |
|
|
|
|
|
|
| hsa-miR-194 |
|
Causal |
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. |
2009 |
|
|
|
|
|
|
| hsa-miR-215 |
|
Causal |
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-17-5p |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-183 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-18a |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-20a |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-31 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-92 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-451 |
|
Causal |
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-18a* |
|
Causal |
The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. |
2009 |
|
|
|
|
|
|
| hsa-miR-196a |
|
Causal |
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. |
2009 |
|
|
|
|
|
|
| hsa-miR-129-2 |
|
Unspecified |
Epigenetic regulation of microRNA expression in colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-137 |
|
Unspecified |
Epigenetic regulation of microRNA expression in colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-9-1 |
|
Unspecified |
Epigenetic regulation of microRNA expression in colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-140 |
|
Causal |
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma |
2009 |
|
|
|
|
|
|